TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.00500nM ΔG°: -67.1kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.00600nMAssay Description:Binding affinity towards human Melanocortin 1 receptor (hMC1R)More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0100nM ΔG°: -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0100nM ΔG°: -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0100nM ΔG°: -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0100nM ΔG°: -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0120nM ΔG°: -64.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0140nM ΔG°: -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0140nM ΔG°: -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0150nM ΔG°: -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0150nM ΔG°: -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0150nM ΔG°: -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0150nM ΔG°: -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0200nM ΔG°: -63.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0250nM ΔG°: -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0250nM ΔG°: -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0250nM ΔG°: -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0300nM ΔG°: -62.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0300nM ΔG°: -62.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0400nM ΔG°: -61.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0400nM ΔG°: -61.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0400nM ΔG°: -61.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0400nM ΔG°: -61.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0460nMAssay Description:Displacement of [125I]-NAD-alpha-MSH from human recombinant MC1 receptor expressed in BHK570 cells after 90 mins in presence of ovalbuminMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0500nM ΔG°: -61.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0500nM ΔG°: -61.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0650nM ΔG°: -60.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0692nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK2936E cell membrane measured after 16-23 hrs by 1450 microbeta trilux scintillat...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0700nM ΔG°: -60.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.0900nMAssay Description:Inhibition of [125I]NDP-alpha-MSH binding to melanocortin-1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.100nMAssay Description:Inhibition of [125I]NDP-alpha-MSH binding to melanocortin-1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.100nM ΔG°: -59.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.112nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R LBD expressed in HEK293 cell membranes incubated for 16 to 23 hrs in dark by scintillation proxi...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.120nM ΔG°: -58.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.132nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK2936E cell membrane measured after 16-23 hrs by 1450 microbeta trilux scintillat...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.148nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK2936E cell membrane measured after 16-23 hrs by 1450 microbeta trilux scintillat...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.150nM ΔG°: -58.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.170nMAssay Description:Displacement of Eu-NDP-alphaMSH from human MC1 receptor expressed in human HCT116 cells after 1.5 hrs by time-resolved fluorescence analysisMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.195nM ΔG°: -57.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.200nM ΔG°: -57.6kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.210nMAssay Description:Inhibition of [125I]NDP-alpha-MSH binding to melanocortin-1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.240nMAssay Description:Displacement of Eu-NDP-alphaMSH from human MC1 receptor expressed in human HCT116 cells after 1.5 hrs by time-resolved fluorescence analysisMore data for this Ligand-Target Pair
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Palatin Technologies Inc
US Patent
Palatin Technologies Inc
US Patent
Affinity DataKi: 0.300nM ΔG°: -56.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
